Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature (2009) 10.59

Endocrine regulation of energy metabolism by the skeleton. Cell (2007) 10.41

Functional interactions between the gut microbiota and host metabolism. Nature (2012) 7.91

TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab (2009) 6.91

High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology (2009) 5.08

Bile acids: regulation of synthesis. J Lipid Res (2009) 4.31

Cellular bioenergetics as a target for obesity therapy. Nat Rev Drug Discov (2010) 4.23

Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med (2013) 4.15

What we talk about when we talk about fat. Cell (2014) 4.12

Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol (2008) 3.82

A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol (2007) 3.68

Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab (2012) 3.64

Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab (2010) 3.46

Bile acids as regulatory molecules. J Lipid Res (2009) 3.23

Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes (2009) 3.17

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) (2009) 3.15

Endocrine functions of bile acids. EMBO J (2006) 3.03

Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev (2008) 2.98

Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat Med (2015) 2.86

Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid (2014) 2.77

NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Cell (2011) 2.75

White to brown fat phenotypic switch induced by genetic and environmental activation of a hypothalamic-adipocyte axis. Cell Metab (2011) 2.68

Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest (2006) 2.56

Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci U S A (2008) 2.53

Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci U S A (2010) 2.52

A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery. Endocrinology (2013) 2.39

A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell (2012) 2.29

Pleiotropic roles of bile acids in metabolism. Cell Metab (2013) 2.25

Regulatory circuits controlling white versus brown adipocyte differentiation. Biochem J (2006) 2.23

TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab (2011) 2.17

Retracted Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis. Hepatology (2013) 2.16

Colonization-induced host-gut microbial metabolic interaction. MBio (2011) 2.04

Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat. Gastroenterology (2010) 1.96

Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nat Rev Drug Discov (2009) 1.92

Interactions between the intestinal microbiome and liver diseases. Gastroenterology (2014) 1.92

A new era in brown adipose tissue biology: molecular control of brown fat development and energy homeostasis. Annu Rev Physiol (2013) 1.86

Absence of thyroid hormone activation during development underlies a permanent defect in adaptive thermogenesis. Endocrinology (2010) 1.81

Fifty years of advances in bile acid synthesis and metabolism. J Lipid Res (2008) 1.74

Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes (2011) 1.73

The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice. Hepatology (2011) 1.71

Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation. Biochem J (2006) 1.70

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology (2012) 1.70

Thyroid hormone regulation of metabolism. Physiol Rev (2014) 1.70

The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J Hepatol (2010) 1.69

Brown adipose tissue--when it pays to be inefficient. N Engl J Med (2009) 1.67

Pharmacological approaches to restore mitochondrial function. Nat Rev Drug Discov (2013) 1.66

A pharmacological organization of G protein-coupled receptors. Nat Methods (2013) 1.65

Metabolite profiling identifies markers of uremia. J Am Soc Nephrol (2010) 1.63

Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure. J Biol Chem (2011) 1.62

Role of cholesterol pathways in norovirus replication. J Virol (2009) 1.61

Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system. Neurogastroenterol Motil (2010) 1.60

Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev (2014) 1.58

Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery. Nat Commun (2015) 1.57

Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J Lipid Res (2012) 1.55

PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab (2011) 1.55

Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice. Hepatology (2010) 1.55

Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities. Am J Physiol Gastrointest Liver Physiol (2010) 1.54

Deciphering the nuclear bile acid receptor FXR paradigm. Nucl Recept Signal (2010) 1.53

Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proc Natl Acad Sci U S A (2014) 1.50

Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion. Br J Pharmacol (2012) 1.48

G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes. J Am Soc Nephrol (2015) 1.47

Adipose tissue-specific inactivation of the retinoblastoma protein protects against diabesity because of increased energy expenditure. Proc Natl Acad Sci U S A (2007) 1.46

Bile acids and the gut microbiome. Curr Opin Gastroenterol (2014) 1.45

Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. J Clin Endocrinol Metab (2013) 1.45

Bile acid metabolism and signaling. Compr Physiol (2013) 1.42

American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models. Thyroid (2013) 1.41

Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum. Hepatology (2015) 1.41

Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges. Endocrinology (2009) 1.40

The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling. Mol Endocrinol (2011) 1.39

Transcriptome Analysis Reveals Regulation of Gene Expression for Lipid Catabolism in Young Broilers by Butyrate Glycerides. PLoS One (2016) 1.38

A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency. Am J Hum Genet (2007) 1.36

Muscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasis. Sci Rep (2012) 1.35

The bile salt export pump. Pflugers Arch (2006) 1.34

Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes. Hepatology (2011) 1.33

The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu Rev Med (2015) 1.33

Skin-specific deletion of stearoyl-CoA desaturase-1 alters skin lipid composition and protects mice from high fat diet-induced obesity. J Biol Chem (2009) 1.31

Bile acid metabolism and the pathogenesis of type 2 diabetes. Curr Diab Rep (2011) 1.30

Negative feedback maintenance of heme homeostasis by its receptor, Rev-erbalpha. Genes Dev (2009) 1.30

Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells. J Clin Invest (2010) 1.29

Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels. J Physiol (2010) 1.29

The TGR5 receptor mediates bile acid-induced itch and analgesia. J Clin Invest (2013) 1.27

Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity. J Biol Chem (2011) 1.27

Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity. Int J Obes (Lond) (2013) 1.24

Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass. Obes Surg (2012) 1.24

TGR5 potentiates GLP-1 secretion in response to anionic exchange resins. Sci Rep (2012) 1.23

The bile acid receptor TGR5 does not interact with β-arrestins or traffic to endosomes but transmits sustained signals from plasma membrane rafts. J Biol Chem (2013) 1.23

Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation. Trends Endocrinol Metab (2009) 1.22

Mechanisms underlying weight loss after bariatric surgery. Nat Rev Gastroenterol Hepatol (2013) 1.21

Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob/ob mice. Mol Endocrinol (2012) 1.21

Type 2 deiodinase expression is induced by peroxisomal proliferator-activated receptor-gamma agonists in skeletal myocytes. Endocrinology (2008) 1.20

Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2012) 1.20

Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma. Gut (2009) 1.20

The arrestin domain-containing 3 protein regulates body mass and energy expenditure. Cell Metab (2011) 1.19

Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration. Diabetes Care (2009) 1.19

Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology (2013) 1.18

Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr Opin Gastroenterol (2012) 1.17

Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis. J Clin Invest (2010) 1.17

Ubiquitination-induced conformational change within the deiodinase dimer is a switch regulating enzyme activity. Mol Cell Biol (2007) 1.17

Tissue-specific function of farnesoid X receptor in liver and intestine. Pharmacol Res (2011) 1.17

The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria. Am J Physiol Renal Physiol (2009) 1.16

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell (2006) 19.16

DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature (2007) 13.56

Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature (2004) 12.36

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature (2009) 10.59

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell (2002) 9.10

Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet (2003) 7.98

TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab (2009) 6.91

Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med (2011) 5.66

Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med (2006) 5.63

Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev (2005) 5.50

Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab (2008) 5.44

Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature (2004) 4.92

Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest (2004) 4.65

betaAR signaling required for diet-induced thermogenesis and obesity resistance. Science (2002) 4.47

Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov (2008) 4.43

Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab (2008) 4.36

SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell (2002) 4.31

Mitonuclear protein imbalance as a conserved longevity mechanism. Nature (2013) 4.18

Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science (2011) 4.16

Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β. Nature (2012) 4.15

Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma. Gene (2006) 4.13

PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol (2009) 4.09

Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A (2003) 4.03

HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature (2009) 3.86

A guide to analysis of mouse energy metabolism. Nat Methods (2011) 3.82

The NAD(+)/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling. Cell (2013) 3.50

International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev (2006) 3.48

Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab (2010) 3.46

Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab (2007) 3.43

Osteoprotection by semaphorin 3A. Nature (2012) 3.40

Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer (2007) 3.36

The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev (2009) 3.23

Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. Cell Metab (2006) 3.22

The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab (2012) 3.18

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) (2009) 3.15

Clinical outcomes of double-balloon endoscopy for the diagnosis and treatment of small-intestinal diseases. Clin Gastroenterol Hepatol (2004) 3.04

Endocrine functions of bile acids. EMBO J (2006) 3.03

Nuclear receptors and the control of metabolism. Annu Rev Physiol (2002) 3.00

NFAT and Osterix cooperatively regulate bone formation. Nat Med (2005) 2.99

Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr (2011) 2.98

Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev (2008) 2.98

Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas. Clin Cancer Res (2005) 2.97

PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. Proc Natl Acad Sci U S A (2003) 2.89

Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid (2014) 2.77

NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Cell (2011) 2.75

LXRs regulate the balance between fat storage and oxidation. Cell Metab (2005) 2.75

Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem (2004) 2.72

E2Fs regulate adipocyte differentiation. Dev Cell (2002) 2.71

Quantitation of brown adipose tissue perfusion in transgenic mice using near-infrared fluorescence imaging. Mol Imaging (2003) 2.68

Sirtuins: the 'magnificent seven', function, metabolism and longevity. Ann Med (2007) 2.64

The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation. Dev Cell (2002) 2.61

Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology (2003) 2.59

Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest (2006) 2.56

Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res (2002) 2.49

Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest (2003) 2.48

Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. Proc Natl Acad Sci U S A (2004) 2.46

Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. Cell Metab (2011) 2.42

Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol (2007) 2.40

Sirtuin functions in health and disease. Mol Endocrinol (2007) 2.38

Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol (2008) 2.35

Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma. Cancer Res (2004) 2.34

Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. Mol Cell (2004) 2.31

The murine homolog of SALL4, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with Sall1 in anorectal, heart, brain and kidney development. Development (2006) 2.27

Adipocyte NCoR knockout decreases PPARγ phosphorylation and enhances PPARγ activity and insulin sensitivity. Cell (2011) 2.26

LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis. Trends Cell Biol (2004) 2.24

Oral-facial-digital type I protein is required for primary cilia formation and left-right axis specification. Nat Genet (2005) 2.24

Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation complex I. Cell Metab (2010) 2.21

A wave of nascent transcription on activated human genes. Proc Natl Acad Sci U S A (2009) 2.18

TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab (2011) 2.17

Perilipin promotes hormone-sensitive lipase-mediated adipocyte lipolysis via phosphorylation-dependent and -independent mechanisms. J Biol Chem (2006) 2.15

Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell (2008) 2.13

Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma. J Exp Med (2005) 2.06

Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J Biol Chem (2004) 2.05

mTOR complex 2 in adipose tissue negatively controls whole-body growth. Proc Natl Acad Sci U S A (2009) 2.05

The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood (2010) 2.05

Vitamin E decreases bone mass by stimulating osteoclast fusion. Nat Med (2012) 2.04